Abuja
,
Nigeria
3 - 6 June 2025
Global Sickle Cell Disease Network, 2025, GSCDN
Presentation schedule and materials
Wednesday, 04 June 2025
17:30
- 19:30
WAT
88
POSTER
Etavopivat reduces incidence of vaso-occlusive crises in patients with sickle cell disease: HIBISCUS trial phase 2 results through 52 weeks
Julie Kanter1; Sophia Delicou2; Fuad El Rassi3; Biree Andemariam4; Miguel R. Abboud5; Marilyn J. Telen6; Jessie Githanga7; Adlette Inati8; Ibrahim Idris9; Sunil Navani10; Eric Wu11; Andrew Eisenberger12
MATERIALS AVAILABLE
17:30
- 19:30
WAT
20
POSTER
Factors driving participation in clinical trials among people with sickle cell disease differ in importance across geographic regions: findings from the global LISTEN survey
Raffaella Colombatti1; John James2; Biree Andemariam3; Johnny Mahlangu4; John Waller5; Samar Al-Behaisi5; Gareth Morrell6; Cassandra Trimnell7
MATERIALS AVAILABLE
17:30
- 19:30
WAT
21
POSTER
Attitudes to participating in clinical trials vary between distinct groups of people with sickle cell disease: global findings from the LISTEN survey
John James1; Biree Andemariam2; Johnny Mahlangu3; Raffaella Colombatti4; John Waller5; Samar Al-Behaisi5; Gareth Morrell6; Cassandra Trimnell7
MATERIALS AVAILABLE
17:30
- 19:30
WAT
24
POSTER
Correlation of non-invasive hemoglobin measurement to vaso-occlusive crises in patients with sickle cell disease
Kunjan Rana1; Rob Mannino2; Wilbur Lam3,4; Inga Hegemann1; Robert Gurecka2; Janne Toftegaard Madsen1 and Erika Tyburski2.
MATERIALS AVAILABLE
Thursday, 05 June 2025
14:30
- 16:00
WAT
TBC
ORAL PRESENTATION
Motivators and barriers for people with sickle cell disease participating in clinical trials: global findings from the LISTEN survey
Biree Andemariam1; John James2; Johnny Mahlangu3; Raffaella Colombatti4; John Waller5; Samar Al-Behaisi5; Adam Wufsus6; Gareth Morrell7; Cassandra Trimnell8
MATERIALS AVAILABLE
Keywords